CrossrefInfokarte
Integrated Pan-Cancer Profiling and Breast Cancer Validation Identify BEND3 as a Potential Prognostic and Immune Biomarker
Breast Cancer: Targets and Therapy · 2025-12 · Volume 17 · 1439-1461
DOI: 10.2147/bctt.s553681 ↗Abstract
Kein Abstract verfügbar.
EUVIMED